A phase II trial of dexamethasone, high-dose cytarabine, and cisplatin (DHAP) in combination with rituximab as salvage treatment for patients with refractory or relapsed aggressive non-Hodgkin's lymphoma.

被引：0
|
作者：
Mey, UJM
Strehl, JW
Orlopp, KS
Flieger, D
Birkmann, J
Ho, A
Kaiser, U
Neubauer, A
Glasmacher, AG
Schmidt-Wolf, IGH
机构：
[1] Univ Bonn, Dept Internal Med 1, D-5300 Bonn, Germany
[2] Klinikum Aschaffenburg, Dept Internal Med 2, Aschaffenburg, Germany
[3] Univ Erlangen Nurnberg, Dept Internal Med 5, Nurnberg, Germany
[4] Univ Heidelberg, Dept Internal Med 5, Heidelberg, Germany
[5] St Bernward Krankenhaus, Dept Internal Med 2, Hildesheim, Germany
[6] Univ Marburg, Dept Internal Med, Marburg, Germany
来源：
BLOOD | 2004年 / 104卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4618
引用
收藏
页码：238B / 238B
页数：1
相关论文
共 50 条
  • [31] Phase II trial of Doxil® in patients with refractory/relapsed low-grade non-Hodgkin's lymphoma.
    Di Bella, NJ
    Khan, MM
    Dakhil, SR
    Logie, KW
    Marsland, TA
    Simon, SR
    Weinstein, RE
    [J]. BLOOD, 2000, 96 (11) : 236B - 236B
  • [32] Two consecutive phase II studies of oxaliplatin based salvage chemotherapy for treatment of patients with refractory or relapsed non-Hodgkin's lymphoma.
    Delmas-Marsalet, B
    Gumus, Y
    Misra, S
    Goldschmidt, E
    Frenoy, N
    Guettier, C
    Brahimi, N
    Ulusakarya, A
    Jasmin, C
    Machover, D
    [J]. BLOOD, 2002, 100 (11) : 297B - 297B
  • [33] Combining Brentuximab Vedotin With Dexamethasone, High-dose Cytarabine, and Cisplatin as Salvage Treatment in Pediatric Relapsed or Refractory Classic Hodgkin Lymphoma: Two Case Reports
    Muggeo, Paola
    Sinisi, Carmen
    Angarano, Rosa
    Daniele, Rosa Maria
    Grassi, Massimo
    Ingravallo, Giuseppe
    Santoro, Nicola
    [J]. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2024, 46 (06) : e439 - e442
  • [34] Idarubicin and high dose cytarabine: A new salvage treatment for refractory or relapsing non-Hodgkin's lymphoma
    Dufour, P
    Mors, R
    Berthaud, P
    Lamy, T
    Bergerat, JP
    Herbrecht, R
    Maloisel, F
    Audhuy, B
    Lioure, B
    Giron, C
    Hurteloup, P
    Oberling, F
    [J]. LEUKEMIA & LYMPHOMA, 1996, 22 (3-4) : 329 - 334
  • [35] Phase II trial for lenalidomide alone in relapsed/refractory aggressive non-Hodgkin lymphoma
    不详
    [J]. CLINICAL LYMPHOMA & MYELOMA, 2007, 7 (05): : 339 - 339
  • [36] Cologne high-dose sequential chemotherapy in relapsed and refractory aggressive non-Hodgkin's lymphoma results of multicenter phase II study
    Josting, A
    Sieniawski, M
    Staak, J
    Diehl, V
    Engert, A
    [J]. ANNALS OF ONCOLOGY, 2005, 16 : 183 - 183
  • [37] Phase II study of paclitaxel in combination with mitoxantrone and ifosfamide/Mesna for patients with relapsed or refractory non-Hodgkin's lymphoma after failure to cytarabine/cisplatin combination
    Romaguera, JE
    Rodriguez, MA
    Hagemeister, FB
    McLaughlin, P
    Rodriguez, J
    Preti, A
    Younes, A
    Sarris, AH
    Cabanillas, F
    [J]. INVESTIGATIONAL NEW DRUGS, 1999, 17 (02) : 187 - 192
  • [38] Phase II Study of Paclitaxel in Combination with Mitoxantrone and Ifosfamide/Mesna for Patients with Relapsed or Refractory Non-Hodgkin's Lymphoma after Failure to Cytarabine/Cisplatin Combination
    Jorge E. Romaguera
    M. Alma Rodriguez
    Fredrick B. Hagemeister
    Peter McLaughlin
    Jose Rodriguez
    Alejandro Preti
    Anas Younes
    Andreas H. Sarris
    Fernando Cabanillas
    [J]. Investigational New Drugs, 1999, 17 : 187 - 192
  • [39] Gemcitabine, dexamethasone, high dose cytarabine and platinum (G-DHAP) is an effective salvage in relapsed and refractory lymphoma
    Rassam, M. B.
    Gupta, S.
    Thanigaikumar, M.
    Hill, M. E.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 526 - 526
  • [40] Salvage chemotherapy with rituximab DHAP (RDHAP) for relapsed non-Hodgkin lymphoma (NHL): A phase II trial in the North Central Cancer Treatment Group.
    Witzig, T. E.
    Geyer, S. M.
    Kurtin, P. J.
    Colgan, J. P.
    Inwards, D. J.
    Micallef, I. N.
    Michalak, J. C.
    Salim, M.
    Nikcevich, D. A.
    Dakhil, S. R.
    Fitch, T. R.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 440S - 440S
12345